Transdermal delivery and cutaneous targeting of antivirals using a penetration enhancer and lysolipid prodrugs.

about

Dodecyl Amino Glucoside Enhances Transdermal and Topical Drug Delivery via Reversible Interaction with Skin Barrier Lipids.Galactosyl Pentadecene Reversibly Enhances Transdermal and Topical Drug Delivery.Exploring unsaturated fatty acid cholesteryl esters as transdermal permeation enhancers.

P2860

Q42803870-4F68BE77-8243-472E-87CC-F57510917388 Q47988106-D4793A4E-705A-447D-A3E7-15025F9B268D Q53526900-74B40EB4-4C1A-44DD-BA87-6FDC4AD837B7

P2860

Transdermal delivery and cutaneous targeting of antivirals using a penetration enhancer and lysolipid prodrugs.

Item

http://www.wikidata.org/entity/Q45084932

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Transdermal delivery and cutan ...... hancer and lysolipid prodrugs.

@en

Transdermal delivery and cutan ...... hancer and lysolipid prodrugs.

@nl

type

Item

label

Transdermal delivery and cutan ...... hancer and lysolipid prodrugs.

@en

Transdermal delivery and cutan ...... hancer and lysolipid prodrugs.

@nl

prefLabel

Transdermal delivery and cutan ...... hancer and lysolipid prodrugs.

@en

Transdermal delivery and cutan ...... hancer and lysolipid prodrugs.

@nl

P1476

Transdermal delivery and cutan ...... hancer and lysolipid prodrugs.

@en

P2093

Denisa Diblíková

http://www.w3.org/2001/XMLSchema#string

Kateřina Vávrová

http://www.w3.org/2001/XMLSchema#string

P2860

Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine

Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine

Penetration enhancers

Design principles of chemical penetration enhancers for transdermal drug delivery.

Novel mechanisms and devices to enable successful transdermal drug delivery.

Acyclic nucleoside phosphonates: a key class of antiviral drugs.

Phosphonomethoxyalkyl analogs of nucleotides.

Amphiphilic transdermal permeation enhancers: structure-activity relationships.

Design for optimized topical delivery: Prodrugs and a paradigm change.

Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication.

P304

1071-1081

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11095-013-1228-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258855181

http://www.w3.org/2001/XMLSchema#string

P698

24271238

http://www.w3.org/2001/XMLSchema#string

Transdermal delivery and cutaneous targeting of antivirals using a penetration enhancer and lysolipid prodrugs.

about

P2860

P2860

Transdermal delivery and cutaneous targeting of antivirals using a penetration enhancer and lysolipid prodrugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698